These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 35288363)
1. CD11b agonists offer a novel approach for treating lupus nephritis. Villanueva V; Li X; Jimenez V; Faridi HM; Gupta V Transl Res; 2022 Jul; 245():41-54. PubMed ID: 35288363 [TBL] [Abstract][Full Text] [Related]
2. CD11b Activity Modulates Pathogenesis of Lupus Nephritis. Khan SQ; Khan I; Gupta V Front Med (Lausanne); 2018; 5():52. PubMed ID: 29600248 [TBL] [Abstract][Full Text] [Related]
3. CD11b activation suppresses TLR-dependent inflammation and autoimmunity in systemic lupus erythematosus. Faridi MH; Khan SQ; Zhao W; Lee HW; Altintas MM; Zhang K; Kumar V; Armstrong AR; Carmona-Rivera C; Dorschner JM; Schnaith AM; Li X; Ghodke-Puranik Y; Moore E; Purmalek M; Irizarry-Caro J; Zhang T; Day R; Stoub D; Hoffmann V; Khaliqdina SJ; Bhargava P; Santander AM; Torroella-Kouri M; Issac B; Cimbaluk DJ; Zloza A; Prabhakar R; Deep S; Jolly M; Koh KH; Reichner JS; Bradshaw EM; Chen J; Moita LF; Yuen PS; Li Tsai W; Singh B; Reiser J; Nath SK; Niewold TB; Vazquez-Padron RI; Kaplan MJ; Gupta V J Clin Invest; 2017 Apr; 127(4):1271-1283. PubMed ID: 28263189 [TBL] [Abstract][Full Text] [Related]
4. Loss of CD11b Accelerates Lupus Nephritis in Lyn-Deficient Mice Without Disrupting Glomerular Leukocyte Trafficking. Gottschalk TA; Hall P; Tsantikos E; L'Estrange-Stranieri E; Hickey MJ; Hibbs ML Front Immunol; 2022; 13():875359. PubMed ID: 35634296 [TBL] [Abstract][Full Text] [Related]
5. Microvesicles in active lupus nephritis show Toll-like receptor 9-dependent co-expression of galectin-3 binding protein and double-stranded DNA. Rasmussen NS; Nielsen CT; Nielsen CH; Jacobsen S Clin Exp Immunol; 2021 Apr; 204(1):64-77. PubMed ID: 33354779 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Wang H; Li T; Chen S; Gu Y; Ye S Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802 [TBL] [Abstract][Full Text] [Related]
8. Pim-1 as a Therapeutic Target in Lupus Nephritis. Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224 [TBL] [Abstract][Full Text] [Related]
9. High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis. Iwamoto T; Dorschner JM; Selvaraj S; Mezzano V; Jensen MA; Vsetecka D; Amin S; Makol A; Osborn T; Moder K; Chowdhary VR; Izmirly P; Belmont HM; Clancy RM; Buyon JP; Wu M; Loomis CA; Niewold TB J Rheumatol; 2022 Apr; 49(4):388-397. PubMed ID: 34782453 [TBL] [Abstract][Full Text] [Related]
10. Identification of monoclonal antibodies against human renal glomerular endothelial cells in lupus nephritis that induce endothelial interferon-alpha production. Hu YC; Tsai IJ; Hsu HY; Chiang BL; Yang YH Arthritis Res Ther; 2021 Jun; 23(1):171. PubMed ID: 34134755 [TBL] [Abstract][Full Text] [Related]
11. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus. Verma J; Arora V; Marwaha V; Kumar A; Das N Lupus; 2005; 14(4):273-9. PubMed ID: 15864913 [TBL] [Abstract][Full Text] [Related]
12. Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus. Zhu H; Mi W; Luo H; Chen T; Liu S; Raman I; Zuo X; Li QZ Arthritis Res Ther; 2016 Jul; 18():162. PubMed ID: 27412348 [TBL] [Abstract][Full Text] [Related]
13. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice. Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N Front Immunol; 2021; 12():653989. PubMed ID: 33868295 [TBL] [Abstract][Full Text] [Related]
14. Urinary levels of the leukocyte surface molecule CD11b associate with glomerular inflammation in lupus nephritis. Kitagawa A; Tsuboi N; Yokoe Y; Katsuno T; Ikeuchi H; Kajiyama H; Endo N; Sawa Y; Suwa J; Sugiyama Y; Hachiya A; Mimura T; Hiromura K; Maruyama S Kidney Int; 2019 Mar; 95(3):680-692. PubMed ID: 30712924 [TBL] [Abstract][Full Text] [Related]
15. Association between the functional ITGAM rs1143679 G/A polymorphism and systemic lupus erythematosus/lupus nephritis or rheumatoid arthritis: an update meta-analysis. Lee YH; Bae SC Rheumatol Int; 2015 May; 35(5):815-23. PubMed ID: 25315704 [TBL] [Abstract][Full Text] [Related]
16. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Alba P; Bento L; Cuadrado MJ; Karim Y; Tungekar MF; Abbs I; Khamashta MA; D'Cruz D; Hughes GR Ann Rheum Dis; 2003 Jun; 62(6):556-60. PubMed ID: 12759294 [TBL] [Abstract][Full Text] [Related]
17. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity. Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559 [TBL] [Abstract][Full Text] [Related]
18. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease. Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297 [TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells. Ichikawa HT; Conley T; Muchamuel T; Jiang J; Lee S; Owen T; Barnard J; Nevarez S; Goldman BI; Kirk CJ; Looney RJ; Anolik JH Arthritis Rheum; 2012 Feb; 64(2):493-503. PubMed ID: 21905015 [TBL] [Abstract][Full Text] [Related]